首页> 外文OA文献 >Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer: Results of an Exploratory Subgroup Analysis of a Phase III Trial

【2h】

Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer: Results of an Exploratory Subgroup Analysis of a Phase III Trial

机译：顺铂/聚氯胺蛋白/芽蛋白/吉西他滨的疗效和安全性是东亚患者先进的非小细胞肺癌的一线治疗：III期试验的探索性亚组分析的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chih-Hsin Yang; Lorinda Simms; Keunchil Park; Jin Soo Lee; Giorgio Scagliotti; Mauro Orlando;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trial. [J] . Yang CH, Simms L, Park K, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2010,第5期

机译：顺铂/培美曲塞与顺铂/吉西他滨作为一线治疗在东亚晚期非小细胞肺癌患者中的疗效和安全性：III期临床试验亚组分析的结果。
2. Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer. [J] . Yi-Long Wu, Shun Lu, Ying Cheng, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2014,第3期

机译：培美曲塞/顺铂对比吉西他滨/顺铂作为中国晚期非鳞状非小细胞肺癌患者的一线治疗的疗效和安全性。
3. Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer. [J] . Yi-Long Wu, Shun Lu, Ying Cheng, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2014,第3期

机译：Pemetrexed / Cisplatin的疗效和安全性与吉西他滨/顺铂作为中国晚期非小细胞肺癌患者的一线治疗。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3 Open-Label Randomized SQUIRE Study [O] . Keunchil Park, Eun Kyung Cho, Maximino Bello, 2017

机译：一线尼西妥单抗联合吉西他滨和顺铂与吉西他滨和顺铂对东亚IV期鳞状非小细胞肺癌患者的疗效和安全性：3期开放标签随机SQUIRE研究的亚组分析
7. Safety and Resource Utilization by Non-small Cell Lung Cancer Histology: Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaïve Patients with Advanced Non-small Cell Lung Cancer [O] . Novello Silvia, Pimentel Francisco Luis, Douillard Jean-Yves, 2010

机译：非小细胞肺癌组织学的安全性和资源利用：培美曲塞加顺铂与吉西他滨加顺铂在晚期放化疗患者中的随机化III期研究结果

Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer: Results of an Exploratory Subgroup Analysis of a Phase III Trial

著录项

引文网络

相似文献

相关主题

期刊订阅